abm drug discovery
Luciferase Stable IGR-CaP1 Cell Line | T6102
- SKU:
- T6102
- Availability:
- 5 to 7 Days Shipment
Description
abm | Luciferase Stable IGR-CaP1 Cell Line | T6102
Luciferase Stable IGR-CaP1 Cell Line was derived from primary prostate cancer. To obtain the IGR-CaP1 cells, a retrovirus was used expressing the luciferase gene (pMEGIX-Luc vector), carrying an expression cassette encoding the firefly luciferase and green fluorescent protein (GFP) genes. The GFP-positive IGR-CaP1 luciferase-expressing cells were sorted for green fluorescence before amplification. The IGR-CaP1 cell line is a unique model derived from a primary tumor, which can reconstitute human prostate adenocarcinoma in animals and generate experimental bone metastases, providing a novel means for understanding the mechanisms of bone metastasis progression and allowing preclinical testing of new therapies.
Biosafety:
II
Organism:
Human
Source Organ:
Prostate
Growth Properties:
Adherent
Morphology:
Polygonal
Clones:
N/A
Passage Number:
N/A
Population Doner:
N/A
Seeding Density:
N/A
Markers:
GFP, luciferase
Applications:
For Research Use Only
Doner Gender:
N/A
Donor Ethnicity:
N/A
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
The base medium for this cell line is Prigrow II medium available at abm
Preservation:
1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) Bioluminescence
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C